Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Haemonetics Corporation (HAE : NYSE)
 
 • Company Description   
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.

Number of Employees: 2,708

 
 • Price / Volume Information   
Yesterday's Closing Price: $56.24 Daily Weekly Monthly
20 Day Moving Average: 544,722 shares
Shares Outstanding: 51.11 (millions)
Market Capitalization: $2,874.52 (millions)
Beta: 0.44
52 Week High: $75.34
52 Week Low: $43.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.02% 8.05%
12 Week 1.30% 9.48%
Year To Date 6.03% 25.59%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
125 Summer Street
-
Boston,MA 02110
USA
ph: 781-848-7100
fax: 781-848-5106
olga.guyette@haemonetics.com http://www.haemonetics.com
 
 • General Corporate Information   
Officers
Christopher A. Simon - Chief Executive Officer;President and Director
William Burke - Executive Vice President; Chief Financial Officer
Dan Goldstein - Vice President; Corporate Controller
Robert Abernathy - Director
Catherine Burzik - Director

Peer Information
Haemonetics Corporation (BJCT)
Haemonetics Corporation (CADMQ)
Haemonetics Corporation (APNO)
Haemonetics Corporation (UPDC)
Haemonetics Corporation (IMTIQ)
Haemonetics Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 405024100
SIC: 3841
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 51.11
Most Recent Split Date: 12.00 (2.00:1)
Beta: 0.44
Market Capitalization: $2,874.52 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.57 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $2.72 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 10.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.70
Trailing 12 Months: 21.71
PEG Ratio: 2.07
Price Ratios
Price/Book: 3.84
Price/Cash Flow: 12.20
Price / Sales: 2.89
EPS Growth
vs. Year Ago Period: 41.30%
vs. Previous Quarter: -22.62%
Sales Growth
vs. Year Ago Period: 17.76%
vs. Previous Quarter: 2.01%
ROE
03/31/22 - 18.57
12/31/21 - 17.33
09/30/21 - 17.19
ROA
03/31/22 - 7.28
12/31/21 - 6.78
09/30/21 - 7.22
Current Ratio
03/31/22 - 1.71
12/31/21 - 2.05
09/30/21 - 2.42
Quick Ratio
03/31/22 - 1.05
12/31/21 - 1.19
09/30/21 - 1.31
Operating Margin
03/31/22 - 13.35
12/31/21 - 12.90
09/30/21 - 13.01
Net Margin
03/31/22 - 4.37
12/31/21 - 2.37
09/30/21 - 3.35
Pre-Tax Margin
03/31/22 - 6.41
12/31/21 - 2.19
09/30/21 - 2.88
Book Value
03/31/22 - 14.66
12/31/21 - 14.30
09/30/21 - 13.69
Inventory Turnover
03/31/22 - 1.56
12/31/21 - 1.57
09/30/21 - 1.58
Debt-to-Equity
03/31/22 - 0.75
12/31/21 - 0.87
09/30/21 - 1.00
Debt-to-Capital
03/31/22 - 42.74
12/31/21 - 46.42
09/30/21 - 49.98
 

Powered by Zacks Investment Research ©